Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zohreh Safipour"'
Autor:
Zohreh Safipour, Joop P. W. van den Bergh, Frank de Vries, Peter Vestergaard, Paddy K.C. Janssen, Johanna H M Driessen, Rogier van der Zanden
Publikováno v:
Osteoporosis International, 33(3), 649-658. Springer-Verlag London Ltd.
Safipour, Z, van der Zanden, R, van den Bergh, J, Janssen, P, Vestergaard, P, de Vries, F & Driessen, J H M 2022, ' The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis ', Osteoporosis International, vol. 33, no. 3, pp. 649–658 . https://doi.org/10.1007/s00198-021-06101-3
Safipour, Z, van der Zanden, R, van den Bergh, J, Janssen, P, Vestergaard, P, de Vries, F & Driessen, J H M 2022, ' The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis ', Osteoporosis International, vol. 33, no. 3, pp. 649–658 . https://doi.org/10.1007/s00198-021-06101-3
Summary: Oral glucocorticoids may increase major osteoporotic fracture risk (MOF) in myasthenia gravis patients. To assess this risk, we performed a case–control study including all Danish patients with a MOF between 1995 and 2011. We also pooled o
Autor:
Zohreh, Safipour, Rogier, van der Zanden, Joop, van den Bergh, Paddy, Janssen, Peter, Vestergaard, Frank, de Vries, Johanna H M, Driessen
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 33(3)
Oral glucocorticoids may increase major osteoporotic fracture risk (MOF) in myasthenia gravis patients. To assess this risk, we performed a case-control study including all Danish patients with a MOF between 1995 and 2011. We also pooled our data wit